Relative Defects in Mucosal Immunity Predict Acute Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 7, 2014, Pages 1056-1059

  August, Keith J ^a   Chiang, K Y ^b   Qayed, Muna ^b   Dulson, Ashley ^b   Worthington White, Diana ^b   Cole, Conrad R ^c   Horan, John T ^b  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Allogeneic hematopoietic cell transplantation; Fecal biomarkers; Graft versus host disease; Gut mucosal immunity

Indexed keywords

BETA DEFENSIN 2; CALCINEURIN INHIBITOR; CALGRANULIN; CD8 ANTIGEN; CELL ADHESION MOLECULE; SOLUBLE CD8 ANTIGEN; SOLUBLE INTRACELLULAR ADHESION MOLECULE 1; STEROID; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; GRAFT RECIPIENT; HUMAN; INTESTINE MUCOSA; MALE; MUCOSAL IMMUNITY; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; PROSPECTIVE STUDY; ACUTE DISEASE; ADVERSE EFFECTS; ALLOTRANSPLANTATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; INFANT; PRESCHOOL CHILD; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNITY, MUCOSAL; INFANT; MALE; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84902104112     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.03.012     Document Type: Article

References (27)

1. Hill G.R., Ferrara J.L. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000, 95:2754-2759.
2. Ferrara J.L., Antin J.H. The pathophysiology of graft-versus-host-disease. Thomas' hematopoietic cell transplantation (4th ed.) 2009, 208-221. Blackwell Publishing, Oxford. F.R. Applebaum, S.J. Forman, R.S. Negrin, K.G. Blume (Eds.).
3. Gautreaux M.D., Deitch E.A., Berg R.D. T lymphocytes in host defense against bacterial translocation from the gastrointestinal tract. Infect Immun 1994, 62:2874-2884.
4. Kuhl A.A., Kakirman H., Janotta M., et al. Aggravation of different types of experimental colitis by depletion or adhesion blockade of neutrophils. Gastroenterology 2007, 133:1882-1892.
5. Blijlevens N.M., Lutgens L.C., Schattenberg A.V., Donnelly J.P. Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy. Bone Marrow Transplant 2004, 34:193-196.
6. Nuding S., Fellermann K., Wehkamp J., Stange E.F. Reduced mucosal antimicrobial activity in Crohn's disease of the colon. Gut 2007, 56:1240-1247.
7. Iskandar H.N., Ciorba M.A. Biomarkers in inflammatory bowel disease: current practices and recent advances. Transl Res 2012, 159:313-325.
8. Leeds J.S., Oppong K., Sanders D.S. The role of fecal elastase-1 in detecting exocrine pancreatic disease. Nat Rev Gastroenterol Hepatol 2011, 8:405-415.
9. Hong L., Ahuja N. DNA methylation biomarkers of stool and blood for early detection of colon cancer. Genet Test Mol Biomarkers 2013, 17:401-406.
10. Bastos Oreiro M., Castilla-Llorente C., de la Guia A.L., et al. Fecal calprotectin in allogeneic stem cell transplantation for the diagnosis of acute intestinal graft versus host disease. Bone Marrow Transplant 2012, 47:1241-1242.
11. Chiusolo P., Metafuni E., Giammarco S., et al. Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation. Blood 2012, 120:4443-4444.
12. Rodriguez-Otero P., Porcher R., Peffault de Latour R., et al. Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease. Blood 2012, 119:5909-5917.
13. Voganatsi A., Panyutich A., Miyasaki K.T., Murthy R.K. Mechanism of extracellular release of human neutrophil calprotectin complex. J Leukoc Biol 2001, 70:130-134.
14. van Rheenen P.F., Van de Vijver E., Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010, 341:c3369.
15. Wehkamp J., Harder J., Wehkamp K., et al. NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 2004, 72:5750-5758.
16. Kapel N., Benahmed N., Morali A., et al. Fecal beta-defensin-2 in children with inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 2009, 48:117-120.
17. Tomkinson B.E., Brown M.C., Ip S.H., et al. Soluble CD8 during T cell activation. J Immunol 1989, 142:2230-2236.
18. Jabri B., Ebert E. Human CD8+ intraepithelial lymphocytes: a unique model to study the regulation of effector cytotoxic T lymphocytes in tissue. Immunol Rev 2007, 215:202-214.
19. August K.J., Chiang K.Y., Bostick R.M., et al. Biomarkers of immune activation to screen for severe, acute GVHD. Bone Marrow Transplant 2011, 46:601-604.
20. Mendez M.P., Monroy Y.K., Du M., et al. Overexpression of sICAM-1 in the alveolar epithelial space results in an exaggerated inflammatory response and early death in Gram negative pneumonia. Respir Res 2011, 12:12.
21. Parkos C.A. Cell adhesion and migration. I. Neutrophil adhesive interactions with intestinal epithelium. Am J Physiol 1997, 273(4 Pt 1):G763-G768.
22. Kayaba H., Hirokawa M., Watanabe A., et al. Serum markers of graft-versus-host disease after bone marrow transplantation. J Allergy Clin Immunol 2000, 106(1 Pt 2):S40-S44.
23. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995, 15:825-828.
24. Jones J.M., Wilson R., Bealmear P.M. Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras. Radiat Res 1971, 45:577-588.
25. van Bekkum D.W., Roodenburg J., Heidt P.J., van der Waaij D. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst 1974, 52:401-404.
26. Cooke K.R., Gerbitz A., Crawford J.M., et al. LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J Clin Invest 2001, 107:1581-1589.
27. Eriguchi Y., Takashima S., Oka H., et al. Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of alpha-defensins. Blood 2012, 120:223-231.